文献速递主动脉疾病外周动脉疾病

日本队列中Endurant与Excluder支架移植物用于血管内动脉瘤修复的长期结局

Long-term Outcomes of the Endurant and Excluder Stent Grafts for Endovascular Aneurysm Repair in a Japanese Cohort.
PubMed 文献 · J Endovasc Ther · 2022-04-13

这项多中心回顾性分析比较了2012年1月至2019年7月日本10家医院中Endurant与Excluder支架移植物用于腹主动脉及髂动脉瘤血管内修复的长期结局。两组术中、围术期及晚期并发症率无统计学显著差异,但Excluder组术后II型内漏发生率更高,Endurant组瘤囊回缩更常见且瘤囊增大率更高,两组患者解剖特征存在显著差异。

要点

  • 两组术中、围术期及晚期并发症率无统计学显著差异。
  • Excluder组术后II型内漏发生率显著高于Endurant组(46.0% vs 28%,p<0.001)。
  • Endurant组瘤囊回缩更常见(40.7% vs 31.7%,p=0.013),但瘤囊增大率也更高(13.0% vs 7.7%,p=0.020)。

核心结论

  • Endurant与Excluder支架移植物在术中、围术期及晚期并发症率方面无统计学显著差异,但患者解剖特征存在显著差异。

研究设计与样本

  • 回顾性分析2012年1月至2019年7月日本10家医院使用Endurant或Excluder支架移植物行腹主动脉及髂动脉瘤血管内修复的病例,Endurant组332例,Excluder组378例。

主要发现

  • Endurant组近端瘤颈长度显著短于Excluder组(31.5±18.6 mm vs 37.4±21.0 mm,p<0.001)。
  • Endurant组近端瘤颈直径显著大于Excluder组(22.4±4.2 mm vs 21.7±3.8 mm,p=0.029)。
  • Endurant组反向锥形近端瘤颈比例显著高于Excluder组(12.1% vs 5.8%,p=0.003)。
  • Endurant组近端瘤颈相关IFU违反率显著高于Excluder组(54.1% vs 46.3%,p=0.039),入路相关IFU违反率也显著更高(8.1% vs 4.0%,p=0.019)。
  • Excluder组双侧髂内动脉栓塞比例显著高于Endurant组(9.3% vs 5.1%,p=0.035)。

关键数值与推荐

  • 术中并发症率Endurant组3.6% vs Excluder组3.7%(p=0.950),围术期并发症率3.6% vs 3.4%(p=0.899),两组无显著差异。
  • 术后II型内漏发生率Excluder组46.0% vs Endurant组28%(p<0.001),Excluder组显著更高。
  • 瘤囊回缩率Endurant组40.7% vs Excluder组31.7%(p=0.013),Endurant组显著更高;瘤囊增大率Endurant组13.0% vs Excluder组7.7%(p=0.020),Endurant组显著更高。
  • Kaplan-Meier曲线和log-rank分析显示两组晚期并发症(p=0.868)和总生存率(p=0.926)无统计学差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To compare the long-term outcomes of the most widely used third-generation stent grafts, the Endurant and Excluder stent grafts, in Japanese patients using a multicenter registry. MATERIALS AND METHODS: A retrospective analysis of endovascular aneurysm repairs for abdominal aortic and iliac artery aneurysms using either the Endurant or the Excluder stent grafts from January 2012 to July 2019 at 10 Japanese hospitals was performed. RESULTS: A total of 332 and 378 repairs using the Endurant and Excluder stent grafts, respectively, were analyzed. Although the patients' characteristics were generally similar in the two groups, the Endurant group exhibited significantly shorter (Endurant: 31.5±18.6 mm, Excluder: 37.4±21.0 mm; p<0.001), larger (Endurant: 22.4±4.2 mm, Excluder: 21.7±3.8 mm; p=0.029), and more reversed tapered (Endurant: 12.1%, Excluder: 5.8%; p=0.003) proximal necks. The incidence of instructions for use (IFU) violations was similar between the two groups (Endurant: 59.0%, Excluder: 54.5%; p=0.223). However, the Endurant group had significantly more proximal neck-related IFU violations (54.1% and 46.3%, respectively; p=0.039), more access-related IFU violations (8.1% and 4.0%, respectively; p=0.019), and fewer bilateral hypogastric artery embolizations (5.1% and 9.3%, respectively; p=0.035) compared with the Excluder group. The incidence of intraoperative (Endurant: 3.6%, Excluder: 3.7%; p=0.950) and perioperative complications (Endurant: 3.6%, Excluder: 3.4%, p=0.899) was equivalent in the two groups. However, there was a significantly higher incidence of postoperative type II endoleaks in the Excluder group (Endurant: 28%, Excluder: 46.0%, p<0.001). Aneurysm sac regression was more frequent in the Endurant group (Endurant: 40.7%, Excluder: 31.7%, p=0.013). The Endurant group also had significantly higher rates of sac increase (Endurant: 13.0%, Excluder: 7.7%, p=0.020). Kaplan-Meier curve and log-rank analyses revealed no statistical differences in late complications (p=0.868) and overall survival (p=0.926). CONCLUSIONS: There were no statistically significant differences between the Endurant and the Excluder stent grafts in terms of intraoperative, perioperative, and late complication rates; however, the anatomical characteristics of the patients were significantly different.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Sekimoto Y, Fujimura N, Matsubara K, et al. Long-term Outcomes of the Endurant and Excluder Stent Grafts for Endovascular Aneurysm Repair in a Japanese Cohort. J Endovasc Ther. 2022. PMID: 35414228. doi:10.1177/15266028221090441

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。